Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05578898 · ClinicalTrials.gov registry record · NA
CLEAR Care Companion Application
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05578898 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 28 participants.
The verdict
NCT05578898, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Hospital readmissions are common after major cancer surgery, leading to poorer patient outcomes, increased mortality and additional costs. In this study, Clinical and Engineering Approaches to Readmission (CLEAR) Care Companion Application, investigators aim to utilize a smartphone application that tracks concerning postoperative symptoms and provides educational interventions to determine if this can minimize delays in communication between patients and medical providers, increase patient satisfaction with the care received, and reduce or lessen the severity of readmissions.
Interventions
- BEHAVIORAL CLEAR Care Companion (CC) application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2022-08-12 |
| Est. Completion | 2024-07-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05578898
The ClinicalTrials.gov registry entry for NCT05578898 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CLEAR Care Companion (CC) application is the first listed.
NCT05578898 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05578898 about?
NCT05578898 is a clinical study titled "CLEAR Care Companion Application". Hospital readmissions are common after major cancer surgery, leading to poorer patient outcomes, increased mortality and additional costs. In this study, Clinical and Engineering Approaches to Readmission (CLEAR) Care Companion Application, investigators aim to utilize a smartphone application that ...
What is the current status of trial NCT05578898?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2022-08-12. Estimated completion is 2024-07-24.
What interventions are being tested in trial NCT05578898?
The interventions under investigation include: CLEAR Care Companion (CC) application (BEHAVIORAL).
Who is sponsoring clinical trial NCT05578898?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.